UK multiple sclerosis risksharing scheme: A new natural history dataset and an improved Markov model

UK multiple sclerosis risksharing scheme: A new natural history dataset and an improved Markov model

Toon andere (1) versies

<p style="text-align:justify;">Objectives: In 2002, the UK's National Institute for Health and Care Excellence concluded that the multiple sclerosis (MS) disease modifying therapies; interferon-β and glatiramer acetate, were not cost effective over the short term but recognised...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Palace, J, Bregenzer, T, Tremlett, H, Oger, J, Zhu, F, Boggild, M, Duddy, M, Dobson, C
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	BMJ Publishing Group 2014

Gelijkaardige items

UK multiple sclerosis risksharing scheme: A new natural history dataset and an improved Markov model (BMJ Open (2014) 4, (e004073))
door: Palace, J, et al.
Gepubliceerd in: (2014)

UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model.
door: Palace, J, et al.
Gepubliceerd in: (2014)

Modelling natural history for the UK multiple sclerosis risk-sharing scheme
door: Palace, J, et al.
Gepubliceerd in: (2013)

Improving the model for the uk ms disease modifying treatment risk sharing scheme analysis: a new natural history dataset.
door: Palace, J, et al.
Gepubliceerd in: (2013)

THE UK MS RISK-SHARING SCHEME: RESULTS FOR YEARS 4 AND 6
door: Duddy, M, et al.
Gepubliceerd in: (2014)

A decade of data for the uk multiple sclerosis risk-sharing scheme.
door: Duddy, M, et al.
Gepubliceerd in: (2013)

The UK Multiple Sclerosis database.
door: Palace, J, et al.
Gepubliceerd in: (1999)

The UK long-term cost-effectiveness study of disease-modifying therapies in multiple sclerosis: lessons from tire first analysis
door: Palace, J, et al.
Gepubliceerd in: (2008)

Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator.
door: Boggild, M, et al.
Gepubliceerd in: (2009)

The multiple sclerosis monitoring study: Progress to date
door: Cooper, C, et al.
Gepubliceerd in: (2004)

The Multiple Sclerosis Risk Sharing Scheme Monitoring Study – early results and lessons for the future
door: Pickin, M, et al.
Gepubliceerd in: (2009)

The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the future.
door: Pickin, M, et al.
Gepubliceerd in: (2009)

Making the diagnosis of multiple sclerosis.
door: Palace, J
Gepubliceerd in: (2001)

The association between sunlight hours and month of birth in multiple sclerosis patients across UK regions
door: Matthews, L, et al.
Gepubliceerd in: (2012)

The natural history of multiple sclerosis.
door: Ebers, G
Gepubliceerd in: (2000)

The natural history of multiple sclerosis.
door: Weinshenker, BG, et al.
Gepubliceerd in: (1987)

Natural history of multiple sclerosis.
door: Ebers, G
Gepubliceerd in: (2001)

Natural history of multiple sclerosis
door: Ebers, G
Gepubliceerd in: (2001)

New and old treatments for multiple sclerosis.
door: Palace, J
Gepubliceerd in: (1998)

Visibility and representation of women in multiple sclerosis research
door: Thomson, A, et al.
Gepubliceerd in: (2019)

Guidelines for differential diagnosis of suspected multiple sclerosis.
door: Palace, J
Gepubliceerd in: (2009)

Modifying disability in progressive multiple sclerosis.
door: Palace, J, et al.
Gepubliceerd in: (2014)

Modifying disability in progressive multiple sclerosis
door: Palace, J, et al.
Gepubliceerd in: (2014)

New treatments and azathioprine in multiple sclerosis.
door: Palace, J, et al.
Gepubliceerd in: (1997)

Early clinical predictors of disease progression in relapsing-remitting multiple sclerosis: the Oxford UK cohort
door: Wakerley, B, et al.
Gepubliceerd in: (2011)

Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
door: Palace, J
Gepubliceerd in: (2009)

The UK MS database
door: Palace, J, et al.
Gepubliceerd in: (2002)

Bone health and multiple sclerosis.
door: Dobson, R, et al.
Gepubliceerd in: (2012)

Multiple sclerosis patients in Japan appear to have less disability compared to the UK
door: Kumar, G, et al.
Gepubliceerd in: (2013)

The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis.
door: Ebers, G, et al.
Gepubliceerd in: (2000)

Thalamic neurodegeneration in multiple sclerosis.
door: Cifelli, A, et al.
Gepubliceerd in: (2002)

Modafinil for multiple sclerosis fatigue: does it work?
door: Littleton, E, et al.
Gepubliceerd in: (2010)

Natural history of primary progressive multiple sclerosis.
door: Ebers, G
Gepubliceerd in: (2004)

Chapter 3 Natural History of Multiple Sclerosis
door: Ebers, G
Gepubliceerd in: (2003)

Natural history of primary progressive multiple sclerosis
door: Ebers, G
Gepubliceerd in: (2004)

Interleukin-17 expression in multiple sclerosis
door: Tzartos, J, et al.
Gepubliceerd in: (2006)

An approach to the identification of targets of autoantibodies in multiple sclerosis
door: Littleton, E, et al.
Gepubliceerd in: (2004)

The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.
door: Cottrell, D, et al.
Gepubliceerd in: (1999)

Multiple sclerosis lesions: insights from imaging techniques.
door: Tomassini, V, et al.
Gepubliceerd in: (2009)

Running a mitoxantrone service for multiple sclerosis
door: Craner, M, et al.
Gepubliceerd in: (2006)